Veristat Executive and Leadership Team

November, 2026

Leadership Overview

Veristat has 5 executives leading key functions including strategy, financial operations, human capital, and organizational leadership.

Committed to advancing complex clinical research, Veristat delivers science-focused solutions for pharmaceutical, biotechnology, and medical device partners globally. This organization prioritizes regulatory excellence and innovative trial support to accelerate life-saving medical breakthroughs.

Leadership Roles at Veristat

  • Chief Executive Officer - Kim McLean Boericke
  • Co-Founder & Chief Executive Officer - David Koster
  • Chief Financial Officer - Joshua Korth
  • President - John Blaser
  • Chief Human Resources Officer - Clint Wolfe
  • Kim McLean Boericke - Chief Executive Officer

    Kim McLean Boericke, the Chief Executive Officer at Veristat, directs the overarching corporate strategy and long-term vision for the clinical research organization. Overseeing global operations, the Chief Executive Officer ensures that all science-focused initiatives align with the rigorous regulatory requirements of pharmaceutical and biotechnology clients. Boericke manages the integration of diverse clinical trial services, driving efficiency across North American and international markets. By fostering a culture of scientific innovation, the Chief Executive Officer maintains the company's competitive edge in the medical device sector. This leadership role involves constant collaboration with the Board to optimize resource allocation and expand service capabilities. Through the implementation of scalable operational frameworks, Kim McLean Boericke directly impacts the successful delivery of complex clinical programs. Ultimately, Boericke secures the firm's reputation as a premier partner for global drug development and regulatory submission success.
    Kim McLean Boericke

    David Koster - Co-Founder & Chief Executive Officer

    David Koster, the Co-Founder & Chief Executive Officer at Veristat, architects the foundational business model and strategic growth trajectory for the organization. Focusing on the expansion of clinical research capabilities, the Co-Founder & Chief Executive Officer drives the development of new service lines tailored to the evolving needs of the medical device and pharmaceutical industries. Koster oversees high-level partnerships, ensuring that the company remains at the forefront of scientific advancement. By analyzing market trends, the Co-Founder & Chief Executive Officer identifies opportunities for geographic growth and operational diversification. This leadership role requires constant engagement with industry stakeholders to maintain the firm's commitment to quality and regulatory compliance. Through the refinement of internal processes, David Koster directly influences the company's ability to support complex clinical trials. Ultimately, Koster sustains the long-term viability and market impact of the organization within the competitive global research landscape.

    Joshua Korth - Chief Financial Officer

    Joshua Korth, the Chief Financial Officer at Veristat, manages the fiscal health and capital allocation strategies necessary to support large-scale clinical research operations. Overseeing financial planning and analysis, the Chief Financial Officer ensures that the organization maintains the liquidity required for sustained investment in scientific infrastructure. Korth directs the budgeting processes that underpin the company's regulatory submission services for biotechnology and medical device clients. By monitoring global economic indicators, the Chief Financial Officer mitigates financial risks associated with international clinical trial expansion. This leadership role involves close coordination with the executive team to align fiscal performance with corporate growth objectives. Through the implementation of robust financial controls, Joshua Korth directly impacts the operational efficiency of the firm. Ultimately, Korth provides the economic stability required for the company to continue delivering innovative research solutions to a diverse global client base.
    Joshua Korth

    John Blaser - President

    John Blaser, the President at Veristat, executes the daily operational directives and service delivery standards that define the company's clinical research performance. Overseeing the execution of clinical trials, the President ensures that all projects meet the stringent quality and regulatory benchmarks expected by biotechnology and pharmaceutical partners. Blaser directs the cross-functional teams responsible for data management, biostatistics, and regulatory affairs. By streamlining project workflows, the President enhances the speed and accuracy of clinical submissions across global markets. This leadership role involves constant interaction with department heads to resolve operational bottlenecks and improve service delivery. Through the application of rigorous scientific standards, John Blaser directly impacts the successful completion of complex medical research programs. Ultimately, Blaser maintains the operational excellence that allows the company to provide consistent, high-value support to clients navigating the challenging landscape of drug and device development.
    John Blaser

    Clint Wolfe - Chief Human Resources Officer

    Clint Wolfe, the Chief Human Resources Officer at Veristat, designs the talent acquisition and organizational development strategies essential for maintaining a high-performing scientific workforce. Overseeing the recruitment of specialized clinical research professionals, the Chief Human Resources Officer ensures that the company possesses the expertise required to support complex pharmaceutical and medical device trials. Wolfe directs internal training programs that foster professional growth and regulatory proficiency across the organization. By cultivating a collaborative corporate culture, the Chief Human Resources Officer drives employee engagement and retention in a competitive global market. This leadership role involves aligning human capital initiatives with the company's broader mission of scientific excellence. Through the optimization of performance management systems, Clint Wolfe directly impacts the operational capacity of the firm. Ultimately, Wolfe secures the human talent necessary to sustain the company's reputation for delivering high-quality clinical research and regulatory support.

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Veristat Top Executives and Leadership Team

    Who leads Veristat?
    Veristat is led by Kim McLean Boericke (Chief Executive Officer), along with executives such as David Koster (Co-Founder & Chief Executive Officer) and Joshua Korth (Chief Financial Officer).
    Who is part of Veristat’s executive team?
    The executive team of Veristat includes leaders such as Kim McLean Boericke (Chief Executive Officer), David Koster (Co-Founder & Chief Executive Officer), Joshua Korth (Chief Financial Officer) and other senior executives.
    How many executives does Veristat have?
    Veristat has 5 executives leading key business areas.
    What roles are included in Veristat’s leadership team?
    The leadership team of Veristat includes roles such as Chief Executive Officer, Co-Founder & Chief Executive Officer, Chief Financial Officer, President, Chief Human Resources Officer.